Amdocs Limited Reports Second Quarter Fiscal 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall St futures mixed ahead of CPI, bank earnings; US-Iran tensions in focus
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- Goldman Sachs Upgrades NIO (NIO) to Buy
- IBM misses Q2 targets as mainframe and software sales disappoint
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Amdocs (DOX) Tops Q2 EPS by 2c, Offers Guidance
May 7, 2020 4:29 PM EDTAmdocs (NASDAQ: DOX) reported Q2 EPS of $1.08, $0.02 better than the analyst estimate of $1.06. Revenue for the quarter came in at $1.05 billion versus the consensus estimate of $1.04 billion.
GUIDANCE:
Amdocs sees Q3 2020 EPS of $1.00-$1.08, versus the consensus of $1.16. Amdocs sees Q3 2020 revenue of $999-1040 million, versus the consensus of $1050 million.
Revenue of approximately $990-$1,040 million, assuming approximately $8 million sequential negative impact from foreign... More